z-logo
open-access-imgOpen Access
Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma
Author(s) -
Cecilia Monge,
Changqing Xie,
Seth M. Steinberg,
Tim Greten
Publication year - 2021
Publication title -
journal of hepatocellular carcinoma
Language(s) - English
Resource type - Journals
ISSN - 2253-5969
DOI - 10.2147/jhc.s311496
Subject(s) - medicine , hepatocellular carcinoma , immunotherapy , adverse effect , carcinoma , gastroenterology , oncology , survival analysis , survival rate , surgery , cancer
Patients with advanced hepatocellular carcinoma have a dismal prognosis; only a subset of patients with advanced HCC will benefit from treatment with immunotherapy. We searched for clinical characteristics predicting exceptional long-term survival in HCC patients treated with immune checkpoint inhibitors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here